Potassium Carbonate → 5-bromo-3-(1-{[3-(1-pyrrolidinyl)propyl]sulfonyl}-4-piperidinyl)-1H-indole-7-carboxamide

HRID 2267495Notes

Reaction equation

HRID 2267495 reaction equation
[NH2:1]S(N)(=O)=O.[Br:6][C:7]1[CH:8]=[C:9]2[C:13](=[CH:14][CH:15]=1)[NH:12][C:11](C(N)=O)=[C:10]2[CH:19]1[CH2:24][CH2:23][N:22]([S:25]([CH2:28][CH2:29][CH2:30]Cl)(=[O:27])=[O:26])[CH2:21][CH2:20]1.[NH:32]1[CH2:36][CH2:35][CH2:34][CH2:33]1.[C:37]([O-:40])([O-])=O.[K+].[K+]>>[Br:6][C:7]1[CH:8]=[C:9]2[C:13](=[C:14]([C:37]([NH2:1])=[O:40])[CH:15]=1)[NH:12][CH:11]=[C:10]2[CH:19]1[CH2:20][CH2:21][N:22]([S:25]([CH2:28][CH2:29][CH2:30][N:32]2[CH2:36][CH2:35][CH2:34][CH2:33]2)(=[O:27])=[O:26])[CH2:23][CH2:24]1

Participants

5

Procedure

Following the general procedure for aminosulfonamide formation outlined in example 2, 5-bromo-3-{1-[(3-chloropropyl)sulfonyl]-4-piperidinyl}-1H-indole-carboxamide (656 mg, 1.41 mmol) and pyrrolidine (505 mg, 7.05 mmol) were allowed to react in the presence of K2CO3 (389.16 mg, 2.82 mmol). The resulting residue was purified by reverse phase HPLC eluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid) to give the title compound (600 mg, 87%).

Workup

  1. customThe resulting residue was purified by reverse phase HPLC
  2. washeluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid)

Sources & evidence

ORD record
ord-b8811802518042b1ae5e4a15f9a8935b
Source dataset
uspto-grants-2010_12
Patent number
US07858796B2

Reaction notes

Loading…